Stuart S. Licht, PhD

2002-2008 Massachusetts Institute of Technology, Cambridge, MA, United States 
 2008-2010 Novartis, Basel, Basel-Stadt, France 
 2010- sanofi-aventis, St. Louis, MO, United States 
"Stuart Spencer Licht"

Licht, Stuart S. A kinetically competent thiyl radical intermediate in ribonucleotide reduction , thesis MIT (1998)

Mean distance: 15.69 (cluster 11)


Sign in to add mentor
JoAnne Stubbe grad student 1998 MIT (Chemistry Tree)
 (A kinetically competent thiyl radical intermediate in ribonucleotide reduction)
Peter G. Schultz post-doc 2000-2001 Scripps Research Institute (Chemistry Tree)
Anthony Auerbach post-doc 2001-2002 SUNY Buffalo


Sign in to add trainee
Amy Weeks research assistant MIT (Chemistry Tree)
Mathew C. Tantama grad student 2008 MIT
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koundinya M, Sudhalter J, Courjaud A, et al. (2018) Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers. Cell Chemical Biology
McManus J, He T, Gavigan JA, et al. (2018) A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities. Slas Discovery : Advancing Life Sciences R & D. 2472555217750386
Deng G, Shen J, Yin M, et al. (2015) Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule. The Journal of Biological Chemistry. 290: 762-74
Lin WC, Licht S. (2014) Poly(ethylene glycol) as a scaffold for high-affinity open-channel blockers of the mouse nicotinic acetylcholine receptor. Plos One. 9: e112088
Zhang B, Yang G, Dai S, et al. (2014) Abstract 5468: SAR650984, a humanized anti-CD38 antibody potently modulates intracellular and extracellular nucleotide levels of cancer cells Cancer Research. 74: 5468-5468
Ding Z, Lennon A, Perron K, et al. (2014) Abstract 5448: PTK7 as a potential therapeutic target in ovarian cancer Cancer Research. 74: 5448-5448
Deng G, Licht S, Shen J, et al. (2014) Abstract 4746: Selective inhibition of mutant IDH1 via small molecule binding to the dimer interface Cancer Research. 74: 4746-4746
Choi KH, Licht S. (2012) ATP-sensitive potassium channels exhibit variance in the number of open channels below the limit predicted for identical and independent gating. Plos One. 7: e37399
Delaisi C, Meaux I, Dos-Santos O, et al. (2012) Abstract 4648: In vitro characterization of spiro-oxindole-based modulators of the MDM2-p53 interaction and their interspecies selectivity. Cancer Research. 72: 4648-4648
Licht S, Cao H, Li Z, et al. (2011) Abstract A226: Mechanism of action of iniparib: Stimulation of reactive oxygen species (ROS) production in an iniparib-sensitive breast cancer cell line. Molecular Cancer Therapeutics. 10
See more...